2,515
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2246634 | Received 02 May 2023, Accepted 07 Aug 2023, Published online: 07 Sep 2023

References

  • World Health Organization. Obesity. [Accessed 2022 Feb 23]. https://www.who.int/en/health-topics/obesity#tab=tab_1
  • Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association, National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, lung, and blood Institute/American Heart association conference on scientific issues related to definition. Circulation. 2004;109:433–22. doi:10.1161/01.CIR.0000111245.75752.C6.
  • Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617–1624. doi:10.1001/archinte.168.15.1617.
  • OECD. Health at a glance 2021: OECD Indicators. Paris: OECD Publishing; 2021 [accessed 2023 Feb 9]. https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2021_ae3016b9-en
  • Institute for Health Metrics and Evaluation (IHME). GBD 2019 cause and risk summary: High body-mass index — level 2 risk; 2020 [accessed 2022 Feb 23]. https://www.healthdata.org/results/gbd_summaries/2019/high-body-mass-index-level-2-risk
  • Valsamakis G, Konstantakou P, Mastorakos G. New targets for drug treatment of obesity. Annu Rev Pharmacol Toxicol. 2017;57(1):585–605. doi:10.1146/annurev-pharmtox-010716-104735.
  • Kumanyika SK. Advancing health equity efforts to reduce obesity: changing the course. Annu Rev Nutr. 2022;42(1):453–480. doi:10.1146/annurev-nutr-092021-050805.
  • Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–1023. doi:10.1038/4441022a.
  • Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414.
  • Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A. 2012;109(2):594–599. doi:10.1073/pnas.1116053109.
  • Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Sci. 2016;352(6285):565–569. doi:10.1126/science.aad3369.
  • Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, Giannoukos G, Boylan MR, Ciulla D, Gevers D , et al. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci. 2014;111(22):E2329–38. PMCID: 24843156. doi:10.1073/pnas.1319284111.
  • Jie Z, Xia H, Zhong S-L, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845. doi:10.1038/s41467-017-00900-1.
  • Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. doi:10.1038/nature11450.
  • Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528(7581):262–266. doi:10.1038/nature15766.
  • Yassour M, Lim MY, Yun HS, Tickle TL, Sung J, Song Y-M, Lee K, Franzosa EA, Morgan XC, Gevers D, et al. Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med. 2016;8(1):17. doi:10.1186/s13073-016-0271-6.
  • Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, Shi J, Zhao S, Liu W, Wang X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–868. doi:10.1038/nm.4358.
  • Litvak Y, Byndloss MX, Tsolis RM, Bäumler AJ. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr Opin Microbiol. 2017;39:1–6. doi:10.1016/j.mib.2017.07.003.
  • Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 2014;588(22):4223–4233. doi:10.1016/j.febslet.2014.09.039.
  • Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M, Kennedy S, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541–546. doi:10.1038/nature12506.
  • Armour CR, Nayfach S, Pollard KS, Sharpton TJ. A metagenomic meta-analysis reveals functional signatures of health and disease in the human gut microbiome. mSystems. 2019 14;4(4):e00332–18. doi:10.1128/mSystems.00332-18.
  • Thingholm LB, Rühlemann MC, Koch M, Fuqua B, Laucke G, Boehm R, Bang C, Franzosa EA, Hübenthal M, Rahnavard A, et al. Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host & Microbe. 2019;26(2):252–64.e10. doi:10.1016/j.chom.2019.07.004.
  • de la Cuesta-Zuluaga J, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS. Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization. Sci Rep. 2018;8(1):11356. doi:10.1038/s41598-018-29687-x.
  • de la Cuesta-Zuluaga J, Corrales-Agudelo V, Carmona JA, Abad JM, Escobar JS. Body size phenotypes comprehensively assess cardiometabolic risk and refine the association between obesity and gut microbiota. Int J Obes. 2018;42(3):424–432. doi:10.1038/ijo.2017.281.
  • Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. doi:10.1038/nature12198.
  • Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat Commun. 2015;6(1):6528. doi:10.1038/ncomms7528.
  • Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895–905. doi:10.1038/nm.3914.
  • Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513(7516):59–64. doi:10.1038/nature13568.
  • Nielsen HB, Almeida M, Juncker AS, Rasmussen S, Li J, Sunagawa S, Plichta DR, Gautier L, Pedersen AG, Le Chatelier E, et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol. 2014;32(8):822–828. doi:10.1038/nbt.2939.
  • Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32(8):834–841. doi:10.1038/nbt.2942.
  • Wu H, Tremaroli V, Schmidt C, Lundqvist A, Olsson LM, Krämer M, Gummesson A, Perkins R, Bergström G, Bäckhed F. The gut microbiota in Prediabetes and diabetes: A population-based cross-sectional study. Cell Metab. 2020;32(3):379–90.e3. doi:10.1016/j.cmet.2020.06.011.
  • Sze MA, Schloss PD, Fraser CM. Looking for a signal in the Noise: Revisiting obesity and the microbiome. MBio. 2016;7(4):e01018–16. doi:10.1128/mBio.01018-16.
  • Zeisel SH, Warrier M. Trimethylamine N-Oxide, the microbiome, and Heart and Kidney disease. Annu Rev Nutr. 2017;37(1):157–181. doi:10.1146/annurev-nutr-071816-064732.
  • de la Cuesta-Zuluaga J, Mueller NT, Álvarez-Quintero R, Velásquez-Mejía EP, Sierra JA, Corrales-Agudelo V, Carmona JA, Abad JM, Escobar JS. Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors. Nutrients. 2019;11(1):51. doi:10.3390/nu11010051.
  • Kim KN, Yao Y, Ju SY, Short chain fatty acids and fecal microbiota abundance in humans with obesity: A systematic review and meta-analysis. Nutrients. 2019 18;11(10):2512. doi:10.3390/nu11102512.
  • Byndloss MX, Bäumler AJ. The germ-organ theory of non-communicable diseases. Nat Rev Microbiol. 2018;16(2):103–110. doi:10.1038/nrmicro.2017.158.
  • Bäumler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016;535(7610):85–93. doi:10.1038/nature18849.
  • Xu H, Cupples LA, Stokes A, Liu C-T. Association of obesity with mortality over 24 Years of weight history: findings from the Framingham Heart study. JAMA Netw Open. 2018;1:e184587. doi:10.1001/jamanetworkopen.2018.4587.
  • Dowd JB, Zajacova A. Long-term obesity and cardiovascular, inflammatory, and metabolic risk in U.S. adults. Am J Prev Med. 2014;46(6):578–584. doi:10.1016/j.amepre.2014.01.016.
  • Reis JP, Loria CM, Lewis CE, Powell-Wiley TM, Wei GS, Carr JJ, Terry JG, Liu K. Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA. 2013;310(3):280–288. doi:10.1001/jama.2013.7833.
  • Pinto Pereira SM, Power C. Life course body mass index, birthweight and lipid levels in mid-adulthood: a nationwide birth cohort study. Eur Heart J. 2013;34(16):1215–1224. doi:10.1093/eurheartj/ehs333.
  • Janssen I, Katzmarzyk PT, Ross R. Duration of overweight and metabolic health risk in American men and women. Ann Epidemiol. 2004;14(8):585–591. doi:10.1016/j.annepidem.2004.01.007.
  • Barrett EL, Kwan HS. Bacterial reduction of trimethylamine oxide. Annu Rev Microbiol. 1985;39(1):131–149. doi:10.1146/annurev.mi.39.100185.001023.
  • Zeng MY, Inohara N, Nuñez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10(1):18–26. doi:10.1038/mi.2016.75.
  • Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, Li J. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway. Biomed Pharmacother. 2018;97:941–947. doi:10.1016/j.biopha.2017.11.016.
  • Palleja A, Mikkelsen KH, Forslund SK, Kashani A, Allin KH, Nielsen T, Hansen TH, Liang S, Feng Q, Zhang C, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol. 2018;3(11):1255–1265. doi:10.1038/s41564-018-0257-9.
  • Garsin DA. Ethanolamine utilization in bacterial pathogens: roles and regulation. Nat Rev Microbiol. 2010;8(4):290–295. doi:10.1038/nrmicro2334.
  • Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182(2):375–387. doi:10.1016/j.ajpath.2012.10.014.
  • Gentile M, Panico S, Rubba F, Mattiello A, Chiodini P, Jossa F, Marotta G, Pauciullo P, Rubba P. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women. Eur J Clin Nutr. 2010;64(8):873–878. doi:10.1038/ejcn.2010.69.
  • Rorato R, Borges BDC, Uchoa ET, Antunes-Rodrigues J, Elias CF, Elias LLK. LPS-Induced low-Grade inflammation increases hypothalamic JNK expression and causes central insulin resistance irrespective of body weight changes. IJMS query. 2017;18(7):1431. doi:10.3390/ijms18071431.
  • Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020;11:571731. doi:10.3389/fimmu.2020.571731.
  • Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 2012;5(4):354–366. doi:10.1038/mi.2012.24.
  • Zhang D, Frenette PS. Cross talk between neutrophils and the microbiota. Blood. 2019;133(20):2168–2177. doi:10.1182/blood-2018-11-844555.
  • Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NMJ, Magness S, Jobin C, Lund PK, Gaetani S. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One. 2010;5(8):e12191. doi:10.1371/journal.pone.0012191.
  • Stumpff F. A look at the smelly side of physiology: transport of short chain fatty acids. Pflugers Arch - Eur J Physiol. 2018;470(4):571–598. doi:10.1007/s00424-017-2105-9.
  • van der Hee B, Wells JM. Microbial regulation of host physiology by short-chain fatty acids. Trends Microbiol. 2021;29(8):700–712. doi:10.1016/j.tim.2021.02.001.
  • Vujkovic-Cvijin I, Sklar J, Jiang L, Natarajan L, Knight R, Belkaid Y. Host variables confound gut microbiota studies of human disease. Nature. 2020;587(7834):448–454. doi:10.1038/s41586-020-2881-9.
  • Ghosh TS, Das M, Jeffery IB, O’Toole PW. Adjusting for age improves identification of gut microbiome alterations in multiple diseases. Elife. 2020;9. doi:10.7554/eLife.50240.
  • Porras AM, Brito IL. The internationalization of human microbiome research. Curr Opin Microbiol. 2019;50:50–55. doi:10.1016/j.mib.2019.09.012.
  • Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555(7698):623–628. doi:10.1038/nature25979.
  • Forslund SK, Chakaroun R, Zimmermann-Kogadeeva M, Markó L, Aron-Wisnewsky J, Nielsen T, Moitinho-Silva L, Schmidt TSB, Falony G, Vieira-Silva S, et al. Combinatorial, additive and dose-dependent drug–microbiome associations. Nature. 2021;600(7889):500–505. doi:10.1038/s41586-021-04177-9.
  • Shakya M, Lo C-C, Chain PSG. Advances and Challenges in Metatranscriptomic analysis. Front Genet. 2019;10:904. doi:10.3389/fgene.2019.00904.
  • Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell. 2013;152(1–2):39–50. doi:10.1016/j.cell.2012.10.052.
  • de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS. Metformin is associated with higher relative abundance of mucin-degrading akkermansia muciniphila and several short- chain fatty acid – Producing microbiota in the gut. Diabetes Care. 2017;40(1):54–62. doi:10.2337/dc16-1324.
  • Siri WE. Body composition from fluid spaces and density: analysis of methods. Tech Measuring Body Compos. 1961;61:223–244.
  • García-Vega ÁS, Corrales-Agudelo V, Reyes A, Escobar JS. Diet quality, food groups and Nutrients associated with the gut microbiota in a nonwestern population. Nutrients. 2020;12(10):2938. doi:10.3390/nu12102938.
  • Karasov TL, Almario J, Friedemann C, Ding W, Giolai M, Heavens D, Kersten S, Lundberg DS, Neumann M, Regalado J, et al. Arabidopsis thaliana and pseudomonas pathogens exhibit stable associations over evolutionary timescales. Cell Host & Microbe. 2018;24(1):168–79.e4. doi:10.1016/j.chom.2018.06.011.
  • Droop AP. Fqtools: an efficient software suite for modern FASTQ file manipulation. Bioinformatics. 2016;32(12):1883–1884. doi:10.1093/bioinformatics/btw088.
  • Jiang H, Lei R, Ding S-W, Zhu S. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinform. 2014;15(1):182. doi:10.1186/1471-2105-15-182.
  • Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047–3048. doi:10.1093/bioinformatics/btw354.
  • Rodriguez-R LM, Gunturu S, Tiedje JM, Cole JR, Konstantinidis KT. Nonpareil 3: Fast estimation of metagenomic coverage and sequence diversity. mSystems. 2018;3(3):e00039–18. doi:10.1128/mSystems.00039-18.
  • Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, Lipson KS, Knight R, Caporaso JG, Segata N, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–968. doi:10.1038/s41592-018-0176-y.
  • de la Cuesta-Zuluaga J, Ley RE, Youngblut ND. Struo: a pipeline for building custom databases for common metagenome profilers. Bioinformatics. 2019;36(7):2314–2315. doi:10.1093/bioinformatics/btz899.
  • Parks DH, Chuvochina M, Waite DW, Rinke C, Skarshewski A, Chaumeil P-A, Hugenholtz P. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat Biotechnol. 2018;36(10):996–1004. doi:10.1038/nbt.4229.
  • R Core Team. R: A language and environment for statistical computing. 2018.
  • Palarea-Albaladejo J, Martín-Fernández JA. zCompositions — R package for multivariate imputation of left-censored data under a compositional approach. Chemom Intellig Lab Syst. 2015;143:85–96. doi:10.1016/j.chemolab.2015.02.019.
  • Quinn TP, Richardson MF, Lovell D, Crowley TM. Propr: An R-package for identifying proportionally abundant features using compositional data analysis. Sci Rep. 2017;7:16252. doi:10.1038/s41598-017-16520-0.
  • van den Boogaart KG, Tolosana-Delgado R. “Compositions”: A unified R package to analyze compositional data. Comput Geosci. 2008;34(4):320–338. doi:10.1016/j.cageo.2006.11.017.
  • Quinn TP, Erb I, Gloor G, Notredame C, Richardson MF, Crowley TM. A field guide for the compositional analysis of any-omics data. Gigascience. 2019;8(9):giz107. doi:10.1093/gigascience/giz107.
  • Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit Anal. 2007;15(3):199–236. doi:10.1093/pan/mpl013.
  • Oksanen J, Simpson G, Blanchet F, Kindt R, Legendre P, Minchin P, O’Hara R, Solymos P, Stevens M, Szoecs E, et al. Vegan: community ecology package. R Package Version 2.3. https://CRAN.R-project.org/package=vegan.
  • Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, Tickle TL, Weingart G, Ren B, Schwager EH, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442. doi:10.1371/journal.pcbi.1009442.
  • Mirzayi C, Renson A, Zohra F, Elsafoury S, Geistlinger L, Kasselman LJ, Eckenrode K, van de Wijgert J, Genomic Standards Consortium, Massive Analysis and Quality Control Society, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021;27(11):1885–1892. doi:10.1038/s41591-021-01552-x.